Association of early post-transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation. Diabetic Medicine. 2025.
High glucose levels after heart transplantation are associated with poorer outcomes. It is important that we test for and manage hyperglycaemia after transplant. ...
Impact of body weight loss on type 2 diabetes remission. Lancet Diabetes Endocrinol 2025.
Losing weight—especially >10% —can dramatically improve the chances of reversing type 2 diabetes, regardless of other clinical factors. In this study, every 1% of weight loss increased the chance of diabetes remission by about 2%. ...
Classification of type 1 diabetes: A pathogenic and treatment-based classification. Diabetes Metab Syndr. 2024.
Some people with type 1 diabetes do not have the classic autoantibodies that are usually present at diagnosis. People with antibody-negative type 1 diabetes appear to have a similar natural history to those with antibody-positive type 1 diabetes. ...
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology. Trends Endocrinol Metab. 2025.
SGLT-2 inhibitors and GLP-1 receptor agonists, new medications that reduce the risk of heart disease in people with and without type 2 diabetes, may have a role to play in mitigating cardiovascular risk in type 1 diabetes. ...